Track topics on Twitter Track topics that are important to you
Bristol-Myers Squibb Co. paid $300mm up front for IFM Therapeutics, a private start-up aiming to treat diseases by targeting ...
Original Article: BMS buys start-up IFM for $300mm up front plus over $2bn in earn-outsNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...